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This article analyses the experiences of the association movement in 
Latin America that brings together individuals and families with rare 
(RD) or low prevalence diseases (LPD). It also looks at their needs from 
global health, social, research and education perspectives. The nature 
of social work assessments and interventions in rare diseases helps us 
better	understand	the	needs	of	people	with	RDs	or	LPDs	and	facilitates	
the creation of associations. Social work aims at consolidating the 
social fabric that will lead to the recognition of RDs as a health and 
social priority at an international level.
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Experiences of the Low Prevalence Diseases
Association Movement in Latin America
 The concept and the definition of ‘rare diseases’ are fun-
damentally based on criteria of prevalence and severity. Rare 
diseases are those in which there is danger of death or chronic 
disability, and low incidence (less than 5 cases per 10,000 peo-
ple in Europe), according to the European Commission (Comis-
ión Europea, 1999) and Posada, Martin-Arribas, Ramirez, Vil-
laverde, and Abaitua (2008). We can find other names, such as 
low frequency disease, minor incidence disease, invisible dis-
ease, forgotten disease, orphan disease, uncommon disease, or 
catastrophic disease. In Latin America, the most frequent name 
is low prevalence disease. The patients and the associations that 
support them emphasize the importance of realizing that rare 
diseases can affect anyone at any stage of life. As the president 
of the Association of Relatives and those affected by Lipodys-
trophies (AELIP), says, “It’s not strange to suffer from a rare dis-
ease. The disease is rare, not the people who suffer them” (Pérez 
de Tudela, 2013). From the medical perspective, rare diseases 
are characterized by a large number and wide diversity of dis-
orders and symptoms that vary not only from one disease to an-
other, but also within the same pathology. The same conditions 
can have different clinical manifestations on different persons. 
Many disorders have a remarkable number of subtypes. It is 
estimated that there are more than 7,000 rare diseases affecting 
the patients’ physical, mental and sensory capabilities.
 The rare diseases (RD) association movement has gained 
considerable strength and recognition in public forums in many 
countries (Carrión, Echandi, Banon, & Pastor, 2015). RDs are not 
circumscribed to races or countries; they can appear at any stage 
of life and anywhere in the world. It is estimated that 42 million 
people are affected by RDs in Latin America (ALIBER, 2016). 
The Latin American Alliance of Rare Diseases (ALIBER) is a 
nonprofit coalition that brings together several organizations of 
families and patients of Rare Diseases (RD) or Low Prevalence 
Diseases (LPD) that exist in Latin America.
 In 2013, the Year of Rare Diseases in Spain, the Association 
for Rare Diseases D’Genes and the Spanish Federation of Rare 
Diseases (FEDER) created ALIBER, with the aims of sharing 
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knowledge and best practices, and improving the situation of 
people and families living with a rare disease in Latin America. 
D´Genes began this initiative after many requests for informa-
tion from Latin American countries, which made evident the 
need for it. The Information and Orientation Service (SIO) of 
FEDER also received an increased number of requests for in-
formation and other assistance from Latin American countries 
(Arcos, Solves, & Rius, 2016). Since 2002 the SIO responded to 
3564 queries, as detailed in figure 1.
Figure 1. Distribution of queries on RD from Latin America received 
by SIO-FEDER since 2012. 
Country         No. of visits
Argentina   961
Mexico    571
Colombia   465
Peru    326
Chile    323
Venezuela   196
Ecuador   104
Uruguay    90
Cuba     86
Brazil     66
Guatemala    64
Bolivia     45
Portugal    45
Costa Rica    37
Panama    32
El Salvador    31
Spain     29
Honduras    23
Paraguay    23
Nicaragua    21
Dominican Republic   19
Andorra     7
TOTAL                 3564
Source: SIO FEDER (http://www.enfermedades-raras.org/)
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 It became clear that there was an urgent need to establish 
a joint collaboration among Spanish-speaking countries to re-
spond to this demand. The 2012 agreement among the FEDER 
foundation, the Colombian Federation of rare diseases (FECO-
ER), and the Spanish Foundation of Help for Guatemala provid-
ed a strong precedent. This agreement marked the beginning of 
this international collaboration. During 2012 and 2013, FEDER 
worked with Latin America to contact other organizations of 
patients interested in participating in the project. The end of 
2012 witnessed the agreement among the Portuguese Feder-
ation of Rare Diseases (FEDRA), the Mexican organization of 
Rare Diseases (OMER), and the Colombian Foundation CRONI-
CARE (Carrión et al., 2015, p. 116).
 Since then, D´Genes, together with Mrs. Elizabeth Zabalza, 
Director of the Spanish Foundation for Help to Guatemala; Mr. 
Javier Guerra, Delegate of Mundo Marfan Latino; and Mrs. 
Claudia Delgado, Delegate of FEDER, planned the first Latin 
American meeting of rare diseases, which was held in October 
2013 in Totana, Murcia, Spain. At this event, the Latin Amer-
ican Alliance of Rare Diseases (ALIBER) was created and its 
first Board of Directors was elected. Its mission included the 
creation of a network of organizations for patients with rare dis-
eases prevalent in Latin America, the coordination of actions to 
strengthen the alliance, creating public awareness of RDs, and 
representing RD patients in local, regional, national and inter-
national agencies. This created a forum of permanent collabo-
ration for sharing knowledge, experiences, and best practices in 
the areas of health, education, and work (ALIBER, 2016). 
 As for its vision, ALIBER seeks to be a coalition that brings 
together and empowers the different associations of RD patients 
in Latin America that defend the rights of the patients and their 
families. It disseminates information about legal rights and in-
equalities affecting people with rare diseases in different parts 
of the world. Towards this end, ALIBER works with other agen-
cies and governments to improve the rights and the quality of 
life for those families. For the first time, in 2014, the International 
Day of Rare Diseases was held, and a Decalogue for the defense 
of the rights of people with rare diseases in Latin America was 
created. The Second Latin American Congress on Rare Diseases 
was held in Lisbon, Portugal, in 2014; the Third Latin American 
Congress on Rare Diseases was held in Guadalajara, Mexico, 
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in July 2015; and the Fourth Latin American Congress on Rare 
Diseases was held in Montevideo, Uruguay in September 2016 
(ALIBER, 2016). 
 It is worth noting that the first congress established the guide-
lines for the subsequent ones (Bañón & Fornieles, 2013). The First 
Latin American Congress on Rare Diseases was held on October 
14-18, 2013, in Totana, Murcia, Spain. It was organized by D’Genes 
and the Spanish Federation of Rare Diseases and convened pro-
fessionals as well as delegates from associations. Participating 
entities included the Colombian Federation of Rare Diseases 
(FECOER), the Argentinian Federation of Diseases of Low Prev-
alence (FADEPOF), the All Together Rare Diseases Association 
Uruguay (ATUERU), the Mundo Marfan Latino, CRONICARE 
Foundation of Colombia, the Ecuadorian Foundation of Patients 
with Lysosomal Storage (FEPEL-DASHA), the Mexican Fed-
eration of Rare Diseases (FEMEXER), the Argentinian Support 
Group for Patients with Rare Diseases (GADAPER), the Mexican 
Association of Patients with Lysosomal Storage (ACOPEL), the 
Mexican Organization of Rare Diseases (OMER), the Paolist As-
sociation of Mucopolysaccharidosis and Rare Diseases (AMPS e 
Rarissimas) of Brazil, the Federation of Rare Diseases of Portugal 
(FEDRA), the Orientation and Information Service of Guatema-
la, and the Augusto Turenne Foundation of Uruguay. As can be 
seen, this international congress brought together a wide range 
of organizations. 
 Without a doubt, the development of an international move-
ment is crucial to promoting solid and enduring improvements 
in diagnosis, treatment, and equitable access to social and psy-
chological educational resources. For this reason, the common 
goal is to make this network as wide as possible. The first con-
gress linked the above-mentioned agencies with EURORDIS, 
the European rare diseases organization. We must ensure, how-
ever, that the conclusions and agreements reached during these 
congresses lead to significant action. One of the most important 
outcomes of these congresses has been the buy-in of all mem-
bers of ALIBER and the election of a Board of Directors. Most 
significantly, the congress generated a climate of cooperation 
that will permeate all future work. It is vital to develop joint 
projects between Spain and Latin America, and to dissemi-
nate positive work models and best practices to other countries 
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(ALIBER, 2016). For this reason, it is also important to share 
information about negative experiences and failed initiatives. 
 ALIBER is currently composed of 26 organizations that rep-
resent 497 associations in 14 countries. Spain is the country with 
the highest number of associations (Spanish Federation of Rare 
Diseases, FEDER: 320 associations), followed by Argentina (Ar-
gentinian Federation of Diseases of Low Prevalence, FADEPOF: 
62), Mexico (Mexican Organization of Rare Diseases, OMER: 
19), Uruguay (All Together Rare Diseases Uruguay, ATUERU: 
17), and Portugal (Federation of Rare Diseases of Portugal, FE-
DRA: 16) (ALIBER, 2016).
 The work of ALIBER in partnership with nonprofit organi-
zations of Latin America has increased public awareness of rare 
diseases and has turned them into more of a political, health and 
social priority by the national health systems of ALIBER-member 
countries (ALIBER, 2016). Victims of rare diseases and their rel-
atives are protagonists in the consolidation of this international 
movement. This movement and related associations have come 
to answer their questions and respond to their needs.
Features and Purpose of Organizations
Related to Rare Diseases
 The following are some of the features that characterize the 
organizations within the rare diseases association movement in 
Latin America: (a) they were founded by patients or their rel-
atives; (b) they have arisen from the need to create a meeting 
point and common work arena; (c) they enable patients to con-
tact each other and meet specialists in their particular health 
area; (d) they offer patients access to treatments and informa-
tion about their pathology and rights; and (e) they aim to influ-
ence public policies and generate changes in the public health 
systems that may improve the quality of life for affected people.
 Patient organizations play a key role in the new biopsycho-
social model of health. These patient organizations are being 
recognized for their knowledge of patients’ needs, their ability 
to collaborate, and their experience in putting RDs on the agen-
da of every country’s health systems (Borrell-Carrió, Suchman, 
& Epstein, 2004). The primary purpose of RD organizations is 
to collaborate with health professionals in the care of patients.
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 The strategic objectives of ALIBER are: to increase public 
awareness of rare diseases as social, educational, work and 
health priorities; to represent people with rare diseases in Latin 
America; and to empower its member agencies. 
 In view of the above objectives and in response to its orga-
nizational mission and vision, ALIBER seeks to:
• Increase social visibility through:
 —Strengthening its strategic communication
     through its web page and other social media
 —Sensitizing key players in RD such as professionals,
     students, patients and governments
 —Bringing together key players in this movement
     through international congresses on Rare Diseases.
• Defend Human Rights through:
 —Establishing working relations and negotiations
     with the pharmaceutical industry for access to
     orphan drugs
 —Promoting the creation of alliances with
     organizations related to health and disability in
     Latin America
 —Increasing political influence and social
     mobilization in an effort to incorporate RD
     in health plans in Latin America
 —Promoting international cooperation
 —Creating a document identifying each country’s
     policy in terms of RD health, education, work
     and research
• Provide Training and Disseminate Knowledge through:
 —Training a critical mass of professionals, doctors
     and researchers through the Latin American
     RD School
 —Promoting a model of care in RDs in each
     country through consensus
 —Establishing Alliances and Solidarity Networks
     to stimulate the multilateral cooperation of all
     sectors and actors related to RD in Latin America
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• Effectively Manage Associations through:
 —Knowing and managing the challenges of the
     associations’ movement in every country.
     This includes identifying the needs and problems
     related to RDs and their demands in terms of
     social participation
 —Promoting the creation of RD organizations and
     associations in Latin America
 —Promoting the participation of associations in
     international RD congresses.
• Engage in Social Action through:
 —The empowerment of associations and the
     development of RD Information and Orientation
     Services (SIO). SIO identifies the needs of affected
     people and thus develops a social action through
     improvement proposals based on knowledge
     of RD reality (ALIBER, 2016). 
Challenges to Safeguarding
Equality of Health Rights
 According to Palau (2010), and Saltonstall and Scott (2013), 
the main health problems of people suffering from RDs include 
misdiagnosis, lack of information, lack of scientific knowledge, 
lack of the appropriate quality care, high cost of the few existing 
drugs and treatment, and inequality of access to treatment and 
care, all of which will be explored below.
Misdiagnosis
 Delays between the onset of the first symptoms and proper 
diagnosis involve high risks to patients’ health. Misdiagnoses 
often lead to inadequate treatment in what could be described 
as the pre-diagnostic labyrinth. The average time between the 
onset of the first symptoms and diagnosis is 5 years, and for 
20% of the sufferers, it can be 10 years or more (FEDER, 2009, 
pp. 43-44). Many more patients are still waiting for a diagno-
sis. FEDER (2009) received more than 3,160 queries from peo-
ple without diagnosis seeking help. According to the ENSERIO 
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study (Study of Health and Social needs of people with a RD 
and their families), more than 40% of people with a diagnostic 
delay receive inadequate treatment or no support whatsoever 
(FEDER, 2009, p. 47). 
 Consequences of the delay can be detrimental to patients 
and their families. This delay deprives patients of the needed 
therapeutic intervention and often results in physical, intellec-
tual and psychological deterioration. All of these could have 
been avoided with a more rapid diagnosis. Moreover, a late di-
agnosis leads to greater difficulty in accessing social help (Avel-
laneda et al., 2007).
Lack	of	information,	scientific
knowledge, and appropriate quality care
 Useful and timely information is needed about the diseases 
and about places where proper help can be obtained. It is im-
portant to highlight that the lack of qualified professionals in 
the RD area represents a serious problem (Esteban, Ruano, 
Guerra, & Motero, 2015). Lack of scientific knowledge makes 
it difficult to develop therapeutic tools, defining intervention 
strategies and identifying appropriate medicines and medical 
approaches. Without combining the different knowledge fields 
associated to RDs, such as physiotherapy, nutrition, psychology, 
social work, etc., people affected can live for years in unstable 
conditions, without competent medical attention or rehabilita-
tion. They often remain excluded from the health care system, 
even after diagnosis. 
High cost of the few existing drugs and treatment
and inequality of access to treatment and care 
 The high cost of health care and drugs, combined with the 
lack of social benefits, causes an impoverishment of the family 
and drastically increases inequality of access to care for RD pa-
tients (Graf & Frank, 2015). There is unequal access to innovative 
treatments due to delays in price setting and refund decisions. 
Additionally, doctors lack experience, and few are involved in 
RD clinical trials. There is also lack of consensus about best 
treatments. 
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Human Rights Related to Education
and Communication: Problems
Integrating School, Work and Society
 Rare or low prevalence diseases have significant adverse im-
pacts on the physical health of the sufferers to the point of endan-
gering their lives. This danger in combination with social and 
relevant psychological processes negatively impacts the well-be-
ing of the patients. RDs may lead to stigmatization, exclusion, 
low self-esteem, loneliness, and discrimination in affective rela-
tions, employment, finances, and/or the way they are represented 
in the media. In fact, when asked, patients often make reference 
to their social, educational and communication needs (FEDER, 
2009; Jaeger, Rojvik, & Berglund, 2015; Pavol, 2015).
 RDs have implications for all areas of life including educa-
tion, job choice, leisure activities, and relationships with friends 
or one’s partner. They can lead to stigmatization, isolation, ex-
clusion from the community, difficulty in obtaining insurance 
(travel, life, mortgage, etc.), and reduction of job opportunities. 
 RDs affect education in particular. Fornieles et al. (2014), 
comment on the following 14 major topics that are relevant to 
RDs in Latin America:
•   It is necessary to create interdisciplinary groups
 that consider rare diseases, gather experiences and
 offer solutions. All key players must be present
 in the group [pupils, teachers (also with rare
 diseases), parents (also with rare diseases), etc.].
•   The lack of understanding of low prevalence diseases
 is common in schools. This ignorance spawns
 prejudices related to what students with these
 conditions can or cannot achieve.
•   It is necessary to identify educational models that
 will effectively mainstream children with RDs.
 These models should lead to innovative projects
 and curricular adaptations.
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•   RDs must become part of primary and secondary
 education curricula. Because of their interdisciplinary  
 nature, they can be incorporated into subjects as
 diverse as science, art, humanities, or new technologies.
•   We must continue the efforts to share information
 and increase sensitization regarding RDs. This
 sensitization should focus on the search for equality
 and social justice in education, health and employment.
•   Students with RDs represent a special challenge to
 their families. Educational institutions should make
 every effort to support families, and particularly
 siblings attending the same school. Families must
 be encouraged not to avoid the problem and not to
 overprotect these children.
•   Students with RDs may become our future doctors,  
 teachers, journalists or managers. Their education
 is important for our society in general, even though
 it represents a challenge. Challenges help people grow.
•   We must pay special attention to the transitions
 between the different stages of education. Ignorance
 of RDs may result in the need to repeat educational
 content at the beginning of every semester or
 academic year, and may lead to the loss of
 educational support. It is particularly necessary
 to support students with RDs as they transition
 from secondary education to college and from
 college to higher university degree programs.
•   Research on education and RDs must increase. It is
 important for researchers to contact persons with
 RDs who have been university students in order to
 identify the hurdles they encountered. Researchers
 are encouraged to visit educational institutions to
 interview students and teachers.
•   Self-image during childhood and adolescence has
 not been taken sufficiently into account. This is
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 significant, given that victims of physically visible
 and invisible RDs may experience discrimination
 and bullying that may damage their self-image.
•   On occasion, students with RDs are excluded from
 extracurricular activities, assuming that they cannot
 or do not want to participate. This may be due to
 teachers’ reluctance. We should examine whether
 this problem can be solved with professional help
 or with the use of a mediator.
•   There is a need to improve the collaboration
 between schools and hospitals, given that some
 pathologies require frequent hospitalizations for
 treatment or due to complications.
•   RDs have become a new field in biomedical
 research. The same level of interest is necessary
 as we look at education. There is a need for original
 alternatives that may facilitate on-campus and
 off-campus education.
•   Experts in teaching and pedagogy must collaborate
 with the Institutes of Education Sciences and
 Teachers Centers to generate proposals for new
 methodologies.
Problems in communication
 During the last 3 years, the FEDER agency has conducted 
an exhaustive analysis of RDs in Spain (Solves, Bañón, & Rius, 
2015). Without a doubt, the same should be done in Latin Amer-
ica, as it would help to gain a better understanding of what citi-
zens know about RDs, as well as assess the level of exposure of 
RDs through the media in each country.
 The role of communication media in the process of inclusion 
or stigmatization is obvious. We know from various studies on 
gender, race and disabilities that the media is capable of facilitat-
ing these processes. An analysis of the media suggests that de-
spite the availability of online information on RDs, they remain 
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vastly unknown to the public at large. In a similar manner, de-
spite progress in recent years, RDs remain an unfamiliar topic for 
journalists and society as a whole (Bañón & Requena, 2014).
 As a result, information professionals face multiple barri-
ers, such as ignorance, unknown terminology, technological 
difficulties, and health and social complexities (Vicente, 2011, p. 
395). These barriers could lead to information errors or avoid-
ance, given that these themes may be considered too complex 
for their audiences. On the other hand, the perception of RD 
patient associations and patient families is that not enough 
progress has been made related to media visibility. Although 
media exposure has increased, it seems to be mostly limited to 
the International Day of RD. As Bañón and Fornieles say, “As 
these actions only take place at a particular moment, they only 
leave a temporary footprint that fails to give a clear picture of 
the existence and nature of those diseases amongst the public” 
(2011, p. 12). 
 From this, it becomes clear that we must carefully examine 
the accuracy, ethics and adequacy of the RD content dissemi-
nated by media such as newspapers, radio, TV and Internet. At 
the same time, it is necessary to influence the priorities of jour-
nalists to make sure RDs receive the coverage they deserve. It 
is also important to generate guidelines to help us interact with 
the media. Bañón and Fornieles (2011, pp. 203-206) propose that:
• The growing interest in RDs shown by the Spanish
 media must be consolidated.
• We must enter a new phase of communication
 about RDs in that the quality of information
 must improve.
• Authoritative sources, including researchers and
 RD patient associations, must be properly used.
• There is a need to better integrate RDs into the
 affairs of communication media.
• Communication professionals need additional
 training in the area of RDs.
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• We should not use sensationalism to portray
 patients with RDs nor describe them as people
 in need of compassion. They should not be
 perceived as strange people.
• The media should investigate what health
 authorities say and what they actually do in
 relation to RDs.
• The attention given to leaders that support RDs
 should not overshadow the defense of the rights
 of patients and their families, and working towards
 better diagnosis, medical research or therapies.
• Media professionals must remember that they are
 also agents for reporting incorrect actions in health,
 social or educational fields.
• Media representation of conflicts or collaboration
 between professionals or public administration
 and patients should be used to reflect upon
 good and bad practice.
Recommendations for
Improving Patient Wellbeing
 The following priorities have been adopted by ALIBER in 
Latin America
• Promote the inclusion of RDs in public health plans
• Promote RD research
• Disseminate RD-related information to patients,
 health workers and the general public
• Train health and social workers in RDs
• Recognize the unique social and health rights of
 RD patients
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• Promote the creation of referral centers to improve
 access to and quality of care for RD patients
• Facilitate access to needed resources for a rapid
 diagnosis
• Encourage the development of and access to drugs
 and therapies for RDs
• Support the RD association movement
• Establish national and international collaborations
 related to RDs (ALIBER, 2016)
 Consistent with the recommendations of Fernández, Loza-
no, and Riano (2015), we propose considering four proposals in 
the political arena:
• Survey Spanish public opinion on a regular basis and
 assess the needs of people with RDs in order to
 formulate social policies that respond to those needs.
• Secure the support of national, regional and local
 governments in the development of comprehensive
 plans related to their areas of competence.
• Provide training, increase sensitization, and
 coordinate specialized health and social services
 that respond to the diverse needs of people with RDs.
• Work towards the necessary coordination and
 reciprocal support that should exist between the
 different government agencies and representatives
 of civil society.
Conclusion
 It is clear that without scientific research, there is no fu-
ture or hope for the over 7,000 rare diseases currently known. 
The real challenge for research in rare diseases is to advance 
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the discovery of treatments and detection of new diseases. It 
is true that progress has been made (Ministerio de Sanidad y 
Consumo, 2003, 2006; Ministerio de Sanidad y de Política Social, 
2009). However, it is also necessary to make progress in com-
munication and in social and educational issues. It is estimated 
that between 6 and 8% of the world population may be affected 
by one of these diseases; that is more than 42 million people 
in Latin America and more than 350 million people worldwide 
(ALIBER, 2016).
 To approach these problems, we need global exposure and 
coordinated efforts and resources at the local, regional and na-
tional levels. These efforts must involve government authori-
ties, professionals, the pharmaceutical industry, the mass me-
dia, patient organizations and society in general (Organización 
Mundial de la Salud [World Health Organization], 2012).  Like-
wise, a multi-faceted strategy is required to respond to the most 
urgent health problems through prevention, planning, and pri-
mary care (Garcia-Ribes, 2006). Social workers are key players 
in the association movement in Latin America. The increase in 
the number of associations and foundations in Latin America 
in recent years has resulted in the need to meet and share ex-
periences, consolidating the Latin American Alliance of Rare 
Diseases (ALIBER) as a worldwide model. 
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